{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:10:46Z","timestamp":1793841046990,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijpharm.2018.06.032","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T19:19:40Z","timestamp":1529090380000},"page":"530-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption"],"prefix":"10.1016","volume":"547","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-0911","authenticated-orcid":false,"given":"Paola","family":"Mura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6000-5079","authenticated-orcid":false,"given":"Serena","family":"Orlandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Cirri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7732-7381","authenticated-orcid":false,"given":"Francesca","family":"Maestrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Casella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Furlanetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.06.032_b0005","first-page":"15","article-title":"Buccal mucosa as a route for systemic drug delivery: a review","volume":"1","author":"Shojaei","year":"1998","journal-title":"J. Pharm. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.06.032_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.07.016","article-title":"Oro-transmucosal drug delivery systems: a review","volume":"140","author":"Madhav","year":"2009","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijpharm.2018.06.032_b0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2011.01.027","article-title":"Advances in oral transmucosal drug delivery","volume":"153","author":"Patel","year":"2011","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.ijpharm.2018.06.032_b0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200241090-00003","article-title":"Oral Mucosal Drug Delivery: clinical pharmacokinetics and therapeutic applications","volume":"41","author":"Zhang","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.06.032_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/10454411910020010301","article-title":"The permeability of oral mucosa","volume":"2","author":"Squier","year":"1991","journal-title":"Crit. Rev. Oral. Biol. Med."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2011.02.008","article-title":"New developments and opportunities in oral mucosal drug delivery for local and systemic disease","volume":"64","author":"Hearnden","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijpharm.2014.05.043","article-title":"Oral transmucosal drug delivery \u2013 current status and future prospects","volume":"471","author":"Sattar","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijpharm.2018.06.032_b0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161210790883778","article-title":"Human buccal mucosa as an innovative site of drug delivery","volume":"16","author":"Campisi","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.06.032_b0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jconrel.2012.05.026","article-title":"Modeling the oral cavity: in vitro and in vivo evaluations of buccal drug delivery systems","volume":"161","author":"Patel","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.06.032_b0050","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0367-326X(02)00190-9","article-title":"In vitro permeation through porcine buccal mucosa of caffeic acid phenetyl ester from a topical mucoadhesive gel containing propolis","volume":"73","author":"Ceschel","year":"2002","journal-title":"Fitoterapia"},{"issue":"5","key":"10.1016\/j.ijpharm.2018.06.032_b0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4103\/0250-474X.78522","article-title":"Formulation and evaluation of mucoadhesive buccal films of enalapril maleate","volume":"72","author":"Semalty","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpb.2008.08.016","article-title":"In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery","volume":"71","author":"Figueiras","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0065","unstructured":"WHO Dermal Absorption: Environmental Health Criteria 235, World Health Organization (WHO), Hanover, Germany (2006)."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2016.08.052","article-title":"Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation","volume":"512","author":"Simon","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0075","series-title":"Drug Absorption Studies: In Situ, In Vitro and In Silico Models","first-page":"89","article-title":"In vivo and in vitro models for assessing drug absorption across the buccal mucosa","author":"Nicolazzo","year":"2008"},{"issue":"2","key":"10.1016\/j.ijpharm.2018.06.032_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(99)00368-3","article-title":"TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa","volume":"194","author":"Nielsen","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.06.032_b0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejpb.2012.10.021","article-title":"The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model","volume":"84","author":"Teubl","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.06.032_b0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejps.2013.02.024","article-title":"In vitro, ex vivo and in vivo examination of buccal absorption of metoprolol with varying pH in TR146 cell culture, porcine buccal mucosa and G\u00f6ttingen minipigs","volume":"49","author":"Holm","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0095","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2012.03.015","article-title":"Evidence-based approach to assess passive diffusion and carrier-mediated drug transport","volume":"15\u201316","author":"Di","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2018.06.032_b0100","series-title":"Drug Absorption Studies: In Situ, In Vitro and In Silico Models","first-page":"167","article-title":"In vitro models for investigations of buccal drug permeation and metabolism","author":"Obradovic","year":"2008"},{"issue":"6","key":"10.1016\/j.ijpharm.2018.06.032_b0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1773-2247(13)50092-X","article-title":"In vitro artificial membrane-natural mucosa correlation of carvedilol buccal delivery","volume":"23","author":"Khdair","year":"2013","journal-title":"J. Drug Del. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0110","unstructured":"FDA, 1997. Guidance for Industry: extended release oral dosage forms: development, evaluation and application of in vitro\/in vivo correlations."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0115","unstructured":"FDA, 2014. Guidance for Industry. SUPAC: Manufacturing Equipment Addendum."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.06.032_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/js970332a","article-title":"Human intestinal permeability","volume":"87","author":"Lennernaas","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0125","unstructured":"ICH Harmonised Tripartite Guideline. Pharmaceutical Development Q8(R2) (2009) International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. Available from: https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q8_R1\/Step4\/Q8_R2_Guideline."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1081\/DDC-43947","article-title":"Development and evaluation of fast-dissolving film of salbutamol sulphate","volume":"31","author":"Mashru","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.ijpharm.2018.06.032_b0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/156720109789941696","article-title":"Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate","volume":"6","author":"Gohel","year":"2009","journal-title":"Curr. Drug Deliv."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.06.032_b0140","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/jps.21907","article-title":"Porcine buccal mucosa as an in vitro model: effect of biological and experimental variables","volume":"99","author":"Kulkarni","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpb.2008.08.016","article-title":"In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery","volume":"71","author":"Figueiras","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jps.2600640405","article-title":"Selection of a reference partitioning system for drug design work","volume":"64","author":"Smith","year":"1975","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.2042-7158.1983.tb02872.x","article-title":"Influence of sodium ion-pair formation on transport kinetics of warfarin through octanol-impregnated membranes","volume":"35","author":"Cools","year":"1983","journal-title":"J. Phar. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0376-7388(00)82401-1","article-title":"Ion transport mediated by inverted micellar aggregates across a phosphatidylcholine-octanol liquid membrane","volume":"15","author":"Kaibarak","year":"1989","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5173(96)04796-5","article-title":"Comparison of passive drug transport through Caco-2 cells and artificial membranes","volume":"147","author":"Camenisch","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0928-0987(97)10019-7","article-title":"Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs\u2019 lipophilicity and molecular weight","volume":"6","author":"Camenisch","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0175","unstructured":"MODDE v. 9.1, MKS Umetrics AB, Sweden."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.06.032_b0180","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejps.2005.11.004","article-title":"Development and evaluation of an in vitro method for high-throughput prediction of human drug absorption. I. Assessment of the artificial membrane composition","volume":"27","author":"Corti","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.06.032_b0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejps.2005.11.005","article-title":"Development and evaluation of an in vitro method for prediction of human drug absorption: II. Demonstration of the method suitability","volume":"27","author":"Corti","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0190","series-title":"Experiments With Mixtures","author":"Cornell","year":"2002"},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.06.032_b0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0378-5173(03)00161-3","article-title":"Prediction of human intestinal permeability using artificial membrane permeability","volume":"257","author":"Sugano","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.06.032_b0200","series-title":"Design of Experiments \u2013 Principles and Applications","author":"Eriksson","year":"2008"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.06.032_b0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/biomet\/58.1.155","article-title":"A note on polynomial response functions for mixtures","volume":"58","author":"CoxDR","year":"1971","journal-title":"Biometrika"},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.06.032_b0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.chemolab.2005.04.010","article-title":"Estimation of the uncertainty of indirect measurements from the propagation of distributions by using the Monte-Carlo method: an overview","volume":"79","author":"Herrador","year":"2005","journal-title":"Chemom. Intell. Lab. Syst."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318304307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318304307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:34:29Z","timestamp":1569976469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318304307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0378517318304307"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.06.032","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}